Free Trial

Raymond James Financial Lowers kneat.com (TSE:KSI) Price Target to C$7.00

kneat.com logo with Medical background

Key Points

  • Raymond James Financial has lowered its price target for kneat.com from C$7.50 to C$7.00 while maintaining an "outperform" rating, indicating a potential upside of 25.67% from the previous close.
  • On the day of the announcement, kneat.com shares fell to C$5.57 with a trading volume significantly above its average, reflecting heightened market activity.
  • kneat.com is focused on developing software for regulated industries, particularly in the life sciences, and offers its Kneat Gx solution for enhanced product and quality management.
  • Looking to export and analyze kneat.com data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

kneat.com (TSE:KSI - Free Report) had its target price trimmed by Raymond James Financial from C$7.50 to C$7.00 in a report issued on Wednesday morning,BayStreet.CA reports. The brokerage currently has an outperform rating on the stock. Raymond James Financial also issued estimates for kneat.com's Q3 2025 earnings at ($0.03) EPS, Q4 2025 earnings at ($0.03) EPS, FY2025 earnings at ($0.04) EPS and FY2026 earnings at ($0.05) EPS.

kneat.com Stock Performance

Shares of KSI stock traded down C$0.12 on Wednesday, hitting C$5.90. 574,272 shares of the stock were exchanged, compared to its average volume of 93,188. The company has a current ratio of 1.43, a quick ratio of 1.50 and a debt-to-equity ratio of 85.50. The firm has a market capitalization of C$551.66 million, a PE ratio of -63.73, a P/E/G ratio of 597.67 and a beta of 1.08. kneat.com has a one year low of C$4.40 and a one year high of C$7.25. The firm's 50 day moving average is C$6.03 and its two-hundred day moving average is C$6.26.

kneat.com Company Profile

(Get Free Report)

kneat.com Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance.

Featured Articles

Should You Invest $1,000 in kneat.com Right Now?

Before you consider kneat.com, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and kneat.com wasn't on the list.

While kneat.com currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

$15 Billion for Cybersecurity: The Government’s Next Big Push
Tesla’s Future Unleashed: Elon’s Robotics Move Changes Everything
Top Trades: Massive Gains and Costly Mistakes to Avoid

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines